These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20170871)

  • 1. Percutaneous revascularization of coronary chronic total occlusions: the new era begins.
    Thompson CA
    JACC Cardiovasc Interv; 2010 Feb; 3(2):152-4. PubMed ID: 20170871
    [No Abstract]   [Full Text] [Related]  

  • 2. Side balloon stenting of the left main bifurcation: a three-year angiographic follow-up.
    Latif F; Heldman AW; Hennebry TA
    J Interv Cardiol; 2009 Dec; 22(6):547-9. PubMed ID: 19735474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan).
    Morino Y; Kimura T; Hayashi Y; Muramatsu T; Ochiai M; Noguchi Y; Kato K; Shibata Y; Hiasa Y; Doi O; Yamashita T; Morimoto T; Abe M; Hinohara T; Mitsudo K;
    JACC Cardiovasc Interv; 2010 Feb; 3(2):143-51. PubMed ID: 20170870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does enoxaparin have enough FINESSE to replace unfractionated heparin in primary percutaneous coronary intervention?
    Goodman SG
    JACC Cardiovasc Interv; 2010 Feb; 3(2):213-4. PubMed ID: 20170879
    [No Abstract]   [Full Text] [Related]  

  • 5. In-stent late total occlusion following left main coronary artery stenting.
    Canbay A; Ozcan O
    Acta Cardiol; 2008 Oct; 63(5):639-40. PubMed ID: 19014010
    [No Abstract]   [Full Text] [Related]  

  • 6. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets and endothelium: two key players in percutaneous coronary intervention.
    Bonello L; Sabatier F; Camoin-Jau L; Paganelli F; Dignat-George F
    Arch Cardiovasc Dis; 2011 Dec; 104(12):601-3. PubMed ID: 22152511
    [No Abstract]   [Full Text] [Related]  

  • 8. Not just another restenosis trial.
    Conti CR
    Clin Cardiol; 2004 Oct; 27(10):539. PubMed ID: 15553300
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.
    Kandzari DE; Rao SV; Moses JW; Dzavik V; Strauss BH; Kutryk MJ; Simonton CA; Garg J; Lokhnygina Y; Mancini GB; Yeoh E; Buller CE;
    JACC Cardiovasc Interv; 2009 Feb; 2(2):97-106. PubMed ID: 19463409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of drug-eluting coronary stents.
    Chodosh A; Korr KS; Burtt D
    Med Health R I; 2008 Oct; 91(10):309-12, 314. PubMed ID: 19044106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of antiplatelet therapy in patients who require anticoagulation.
    Henkel DM; Holmes DR
    J Invasive Cardiol; 2009 Apr; 21(4):186-9. PubMed ID: 19342758
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
    Mehilli J; Kastrati A; Schühlen H; Dibra A; Dotzer F; von Beckerath N; Bollwein H; Pache J; Dirschinger J; Berger PP; Schömig A;
    Circulation; 2004 Dec; 110(24):3627-35. PubMed ID: 15531766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
    Mixon T; Fitzsimmons P
    J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of drug-eluting stent restenosis.
    Ishikawa K; Aoyama Y; Hirayama H
    J Invasive Cardiol; 2012 Apr; 24(4):178-82. PubMed ID: 22477755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do hybrid procedures have proven clinical utility and are they the wave of the future? : hybrid procedures have no proven clinical utility and are not the wave of the future.
    Leacche M; Zhao DX; Umakanthan R; Byrne JG
    Circulation; 2012 May; 125(20):2504-10; discussion 2510. PubMed ID: 22615421
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.
    Mirabella F; Francaviglia B; Capodanno D; Di Salvo ME; Galassi AR; Ussia GP; Capranzano P; Tamburino C
    J Invasive Cardiol; 2009 Apr; 21(4):145-50. PubMed ID: 19342750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons.
    Bonaventura K; Sonntag S; Kleber FX
    EuroIntervention; 2011 May; 7 Suppl K():K106-11. PubMed ID: 22027718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents: safe but not sufficient.
    Vogel RA
    JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiology 2007].
    Hoppe UC; Erdmann E
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1365-7. PubMed ID: 17570081
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of chronic kidney disease and diabetes on percutaneous coronary intervention outcomes.
    Lepor NE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S38-48. PubMed ID: 17224890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.